The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.

VECT-HORUS’ business model is to make its technology platform available to pharmaceutical and biotech partners to transport their drug to the brain and other organs using feasibility studies. Subsequently, the Company will license-out its technology. VECT-HORUS is also building proprietary compounds that will be licensed out to industrial partners. Therefore, the Company is always interested in initiating contacts with potential pharma partners located in Western Europe, US and Asia through the BIO International convention. This event is an unrivalled forum for VECT-HORUS to meet its future partners and do business. Come and meet us thanks the partnering system or contact directly Elodie DORMES, Business Developer.